301 related articles for article (PubMed ID: 9292952)
21. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
22. [Antithyroid drug-induced agranulocytosis. A rare but dreaded condition].
Lehtihet M; Zedenius J; Helldén A; Axelsson R; Calissendorff J
Lakartidningen; 2009 Oct 7-13; 106(41):2607-8, 2610-1. PubMed ID: 19927925
[No Abstract] [Full Text] [Related]
23. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
Cepková J; Gabalec F; Svilias I; Horáček J
Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
[TBL] [Abstract][Full Text] [Related]
24. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.
Cho YY; Shon HS; Yoon HD
Korean J Intern Med; 2005 Dec; 20(4):335-8. PubMed ID: 16491833
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.
Dai WX; Zhang JD; Zhan SW; Xu BZ; Jin H; Yao Y; Xin WC; Bai Y
Endocr J; 2002 Feb; 49(1):29-33. PubMed ID: 12008747
[TBL] [Abstract][Full Text] [Related]
26. [Fever due to antithyroid agents].
Shamelian SO; Nortier JW
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):225-8. PubMed ID: 10086149
[TBL] [Abstract][Full Text] [Related]
27. Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): a case report.
Chien MN; Wang CH; Tsan KW
Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):351-5. PubMed ID: 8605651
[TBL] [Abstract][Full Text] [Related]
28. [Development of agranulocytosis by the administration of an antithyroid drug, Mercazole, followed by a successful surgical treatment combined with administration of inorganic iodine and propranolol in a case of Basedow's disease].
Kanaoka M; Gozen T; Iida Y; Endo K; Konishi J
Horumon To Rinsho; 1983 Jan; 31(1):51-4. PubMed ID: 6189651
[No Abstract] [Full Text] [Related]
29. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
Alexander EK; Larsen PR
J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
[TBL] [Abstract][Full Text] [Related]
30. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum granulocyte colony-stimulating factor levels in patients with Graves' disease.
Iitaka M; Noh JY; Kitahama S; Fukasawa N; Miura S; Kawakami Y; Kawasaki S; Yamanaka K; Ishii J; Katayama S; Ito K
Clin Endocrinol (Oxf); 1998 Mar; 48(3):275-80. PubMed ID: 9578815
[TBL] [Abstract][Full Text] [Related]
32. Resolution of drug-induced agranulocytosis.
Mylonakis E; Akhtar MS; Lopez F; Hussain SI; Chen JL; Koutkia P; Lamberton P; Schiffman FJ
Geriatrics; 2000 Feb; 55(2):89-91. PubMed ID: 10711310
[No Abstract] [Full Text] [Related]
33. Agranulocytosis secondary to propylthiouracil.
Khaliq W; Ponor L; Cheripalli P; Tangella K; Chaudhry Z
QJM; 2012 Nov; 105(11):1109-11. PubMed ID: 21920992
[No Abstract] [Full Text] [Related]
34. Severe pancitopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
Macia M; Méndez M; Fernández J; Rivero A; Rios P
Clin Nephrol; 1997 Jan; 47(1):69-70. PubMed ID: 9021251
[No Abstract] [Full Text] [Related]
35. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
[TBL] [Abstract][Full Text] [Related]
37. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
[TBL] [Abstract][Full Text] [Related]
38. Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor.
Adorf D; Grajer KH; Kaboth W; Nerl C
Clin Investig; 1994 May; 72(5):390-2. PubMed ID: 7522068
[TBL] [Abstract][Full Text] [Related]
39. Delayed anithyroid drug-induced agranulocytosis.
Mutharasan P; Oatis W; Kwaan H; Molitch M
Endocr Pract; 2012; 18(4):e69-72. PubMed ID: 22297058
[TBL] [Abstract][Full Text] [Related]
40. [Agranulocytosis/granulocytopenia after long-term use of thiamazole].
Stellingwerf M; Jellema WT; Eland IA; Wakelkamp IM
Ned Tijdschr Geneeskd; 2011; 155():A2430. PubMed ID: 21262008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
